REFERENCES
Bolte, E. R. (1998). Autism and clostridium tetani. Medical Hypotheses, 51, 133–144.
Chez, M. G., Buchanan, C., Field-Chez, M., Loeffel, M. F., & Hammer, M. S. (1998). Treatment of electrencephalographic epileptiform activity on overnight EEG studies in children with pervasive developmental disorder or autism: defining similarities to the Landau-Kleffner syndrome. Journal of Development and Learning Disorders, 2, 217–229.
Deonna, T. (1995). Cognitive and behavioral disturbances as epileptic manifestations in children: An overview. Seminars in Pediatric Neurology, 2, 254–260.
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Vaisanen, M. L., Nelson, M. N., & Wexler, H. M. (1999). Transient benefit from oral vancomycin treatment of regression onset autism. Journal of Child Neurology, (in press).
Tuchman, R. F., & Rapin, I. (1997). Regression in pervasive developmental disorders: Seizures and epileptiform electroencephalogram correlates. Pediatrics, 99, 560–566.
Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Harvey, P., Valentine, A., Davies, S. E., & Walker-Smith, J. A. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 28, 637–641.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chez, M.G., Buchanan, C.P. Reply Reply to B. Rimland's “Comments on ‘Secretin and Autism: A Two-Part Clinical Investigation’”. J Autism Dev Disord 30, 97–98 (2000). https://doi.org/10.1023/A:1005499220232
Issue Date:
DOI: https://doi.org/10.1023/A:1005499220232